ReviewEuropean heart journal. Cardiovascular pharmacotherapy2016

Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion.

Faiez Zannad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.